Erratum to: “Relationship of Ketamine’s Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression” by Zarate et al. (Biol Psychiatry 2012; 72(4): 331–338).

Erratum

Biological Psychiatry

Erratum to: “Relationship of Ketamine’s Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression” by Zarate et al. (Biol Psychiatry 2012; 72(4): 331–338). The authors discovered that some of the lines in Figure 4 are misplaced. In the original, data were inadvertently placed

in the incorrect location in the graphic template. The corrected figure is provided here. The figure legend was correct in the original and remains unchanged. The results suggest a significant main effect for diagnosis and no main effect or interaction with response for HNK4a.

Figure 4. Hydroxynorketamine (HNK) 4a plasma concentrations by response and diagnosis in patients with treatment-resistant depression. Hydroxynorketamine 4a plasma concentrations were significantly higher in patients with bipolar depression (BD) than in patients with major depressive disorder (MDD).

SEE COMMENTARY ON PAGE

http://dx.doi.org/10.1016/j.biopsych.2016.05.014 ISSN: 0006-3223

257 & 2016 Society of Biological Psychiatry. Biological Psychiatry August 1, 2016; 80:257 www.sobp.org/journal